Modifying an obesity drug could reduce side effects like anxiety and depression

April 28, 2016, Elsevier

A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.

The researchers behind the study, from RTI International in the US, say this means the new version of the could be used in the future for treating obesity. And their approach could also support the development of drugs to tackle liver disease, and .

In our bodies we have that control appetite, mood, memory and pain. The obesity drug Rimonabant stops these receptors from working. But the drug was found to have serious psychiatric side effects in a small number of the people who took it. Because of this, the drug was never approved in the US and manufacturer Sanofi-Aventis pulled from the European market voluntarily.

In the new study, the researchers altered the drug so it no longer gets into the brain, which stops it from having psychiatric side effects.

Study author Dr. Rangan Maitra, from RTI International in the US, explained: "There is a real need for new medicines to treat metabolic conditions like obesity. We are working with chemists to alter the drug Rimonabant and create compounds that cannot get into the brain. We hope this will help create drugs that can treat people with these conditions, without them having to suffer the ."

Dr. Maitra and colleagues modified the original Rimonabant compound by changing its weight, polarity and other properties to try to stop it from getting into the brain.

Tests in rats found that one of the versions, called 8c, blocks the target receptor and is much less likely than the original drug to get into the brain and affect the central nervous system.

The researchers found that 8c mostly stays in the blood and works on cannabinoid receptors found in parts of the body other than the brain. In comparison, more than half of the original drug Rimonabant entered the brain.

It's early days for the research, and the new version of the drug will need to go through testing before it can be used to treat people, but the researchers say it's a step in the right direction. Their study also outlines how scientists can test drugs designed to target cannabinoid receptors to make sure they are working outside the brain.

"Drug development is a long and arduous process," said Dr. George Amato, co-author of the study. "You have to develop hundreds, if not thousands, of compounds before you get the right one. The challenge is that some medicines that are absorbed in the gut also get into the brain. We set out to find compounds that absorb across the gut barrier but not the barrier. We've identified some, and they'll now serve as lead structures for further refinement."

Explore further: New drug could help maintain long-term weight loss

More information: Alan Fulp et al, Pyrazole antagonists of the CB1 receptor with reduced brain penetration, Bioorganic & Medicinal Chemistry (2016). DOI: 10.1016/j.bmc.2016.01.033

Related Stories

New drug could help maintain long-term weight loss

July 26, 2012
A new drug could aid in losing weight and keeping it off. The drug, described in the journal Cell Metabolism on July 26, increases sensitivity to the hormone leptin, a natural appetite suppressant found in the body. Although ...

Common cholesterol drug stimulates the same receptors as marijuana

April 1, 2015
If you want the benefits of medical marijuana without the "unwanted side effects" of cannabis, new research should leave you on a high note. According to a research report appearing in the April 2015 issue of The FASEB Journal, ...

Recommended for you

Protein droplets keep neurons at the ready and immune system in balance

August 15, 2018
Inside cells, where DNA is packed tightly in the nucleus and rigid proteins keep intricate transport systems on track, some molecules have a simpler way of establishing order. They can self-organize, find one another in crowded ...

New research suggests it's all about the bass

August 15, 2018
When we listen to music, we often tap our feet or bob our head along to the beat – but why do we do it? New research led by Western Sydney University's MARCS Institute suggests the reason could be related to the way our ...

Self-control develops gradually in adolescent brain

August 15, 2018
Different parts of the brain mature at different times, which may help to explain impulsive behaviors in adolescence, suggest researchers from Penn State and the University of Pittsburgh.

Research reveals that what we see is not always what we get

August 15, 2018
Researchers are helping to explain why some people anticipate and react to fast-moving objects much quicker than others.

New approach to treating chronic itch

August 15, 2018
Researchers at the University of Zurich have discovered a new approach to suppressing itch by targeting two receptors in the spinal cord with the right experimental drug. In a series of experiments in mice and dogs, they ...

Immune cells in the brain have surprising influence on sexual behavior

August 14, 2018
Researchers have found a surprising new explanation of how young brains are shaped for sexual behavior later in life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.